Syndax Pharmaceuticals (SNDX) Revenue Growth (3y) (2018 - 2024)
Syndax Pharmaceuticals (SNDX) Revenue Growth (3y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Syndax Pharmaceuticals | 1.83 Bn | 1.48 Bn | 53.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -60.71% |
| Sep 30, 2024 | 0.34% |
| Jun 30, 2024 | 109.80% |
| Dec 31, 2021 | 593.20% |
| Sep 30, 2021 | 219.62% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | -31.71% |
| Sep 30, 2020 | 7.51% |
| Jun 30, 2020 | 7.51% |
| Mar 31, 2020 | 7.51% |
| Dec 31, 2019 | 7.60% |
| Sep 30, 2019 | 7.51% |
| Jun 30, 2019 | 7.51% |
| Mar 31, 2019 | 7.51% |
| Dec 31, 2018 | 7.60% |
| Sep 30, 2018 | 7.51% |
| Jun 30, 2018 | 181.45% |